France· FR:61258225
PROHANCE 0,5 mmol/mL, solution injectable en seringue pré-remplie
A gadoteridol product containing gadotéridol, registered in France by BRACCO IMAGING FRANCE. The same ATC class is registered in 14 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Gadoteridol is registered in 14 of 19 countries.
Countries holding a registration under ATC V08CA04 (gadoteridol), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 7 of them publish a price we can compare per daily dose
Gadoteridol · ATC V08CA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- GADOTÉRIDOL
- Manufacturer
- BRACCO IMAGING FRANCE
- Country
- France (FR)
- ATC code
- V08CA04
- ATC class
- Gadoteridol
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 6
- cip1334009300118671 seringue(s) préremplie(s) en verre de 17 ml avec nécessaire d’administration pour injection manuelle (seringue, raccord, perforateur et cathéter).
- cip1334009300118811 seringue(s) préremplie(s) en verre de 17 ml avec nécessaire d’administration pour injecteur automatique Spectris Solaris (seringue, raccord, perforateur et cathéter).
- cip1334009302196691 seringue(s) préremplie(s) en verre de 17 ml avec nécessaire d’administration pour injecteur automatique Optistar (seringue, raccord, perforateur et cathéter).
- cip1334009350827181 seringue(s) préremplie(s) en verre de 10 ml
- cip1334009350828861 seringue(s) préremplie(s) en verre de 15 ml
- cip1334009350829471 seringue(s) préremplie(s) en verre de 17 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for gadoteridol.
Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gadoteridol · interactions on record
19 records
- 19 moderate
Most severe, free to view
- PindololC07AA03moderate
- PropranololC07AA05moderate
- TimololC07AA06moderate
- SotalolC07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gadoteridol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandProHance 0.5 mmol/ml, soluzione iniettabile (flacone)Bracco Suisse SA
- BelgiumProhance 279.3 mg/mlBracco Imaging Deutschland
- CzechiaPROHANCEBracco Imaging Deutschland GmbH, Konstanz
- United KingdomProHance 0.5mmol/ml solution for injection 10ml pre-filled syringesBracco UK Ltd
- United StatesGADOTERIDOLSlate Run Pharmaceuticals, LLC
- IrelandProHance, 279.3 mg/ml, Solution for Injection, 10 ml vialBracco International B.V.
- FinlandProhanceBracco International B.V.
- GermanyProhanceEurocontrast Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Prohance
- Belgium · Prohance
- Czechia · Prohance
- Germany · Prohance
- Denmark · Prohance
- Estonia · Prohance
- Spain · Prohance
- Finland · Prohance
- United Kingdom (Northern Ireland) · Prohance
- Greece · Prohance
- Croatia · Prohance
- Hungary · Prohance
- Ireland · Prohance
- Italy · Prohance
- Lithuania · Prohance
- Luxembourg · Prohance
- Latvia · Prohance
- Netherlands · Prohance
- Norway · Prohance
- Poland · Prohance
- Portugal · Prohance
- Romania · Prohance
- Sweden · Prohance
- Slovenia · Prohance
- Slovakia · Prohance
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac625bc4-56b9-44a4-88f1-39575a97144b GET /v1/drugs/ac625bc4-56b9-44a4-88f1-39575a97144b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61258225",
"date_amm": "1999-04-16",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "GADOTÉRIDOL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about gadoteridol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.